Spero Therapeutics (SPRO) EBIT Margin Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,211.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,993.00 |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | 345,812.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 345,812.00 |
| Dec 31, 2025 | -58,693.00 |
| Sep 30, 2025 | 43,654.00 |
| Jun 30, 2025 | 129,136.00 |
| Mar 31, 2025 | 120,920.00 |
| Dec 31, 2024 | 9,417.00 |
| Sep 30, 2024 | -2.54 Mn |
| Jun 30, 2024 | 55,753.00 |
| Mar 31, 2024 | 11,492.00 |
| Sep 30, 2023 | 4.92 Mn |
| Jun 30, 2023 | 59,524.00 |
| Mar 31, 2023 | -503,820.00 |
| Dec 31, 2022 | 387,841.00 |
| Sep 30, 2022 | -19,465.00 |
| Jun 30, 2022 | 1.91 Mn |
| Mar 31, 2022 | -138,618.00 |
| Dec 31, 2021 | 47,698.00 |
| Sep 30, 2021 | -151,950.00 |
| Jun 30, 2021 | 127,313.00 |
| Sep 30, 2020 | -4.84 Mn |
| Jun 30, 2020 | 301,250.00 |
| Mar 31, 2020 | 408,623.00 |
| Dec 31, 2019 | -1.73 Mn |
| Sep 30, 2019 | 752,664.00 |